Exploratory Study of Percutanous Microwave Coagulation Therapy for Liver Cancer by Combining 125I Seed Brachytherapy in a Rabbit VX2 Tumor Model

YU Dong-sheng,YANG Ren-jie,QU Wei-li,LI Zi-xiang
DOI: https://doi.org/10.3321/j.issn:1003-3289.2007.09.001
2007-01-01
Abstract:Objective This study was undertaken to explore a combination therapy with percutanous microwave coagulation therapy(PMCT) and 125I seed brachytherapy for liver cancer,to determine if it can increase the therapy efficiency compared with PMCT alone or 125I seed brachytherapy alone in a Rabbit VX2 tumor Model.Methods Eighty New Zealand white rabbits were implanted with VX2 tumor in the deep aspect of the left lobe of liver.After monitoring with B-ultrasound that 2 cm diameter tumors were observed,rabbits were classified into four groups.Initially,tumor were treated with(a) PMCT(power at 40 W for 2 minutes) alone,(b) 125I seed brachytherapy alone.The activity of per seed was 0.5 mCi.The peripheral radiation total dose was 60 Gy,(c) the combination therapy with PMCT and 125I seed brachytherapy,(d) no treatment.The rabbits were examined by CT for plan before treatment.(a),(b) and(c) CT-guide percutanous treatment and taken plain film for prove the plan after 2 days after treatment.Tumors were measured after 3 weeks treatment by excision and done pathologic examination with HE dye and done electron microscope examination.Results Mean volume for treated tumors were as following:(a)(33.6±12.3) cm3,PMCT alone;(b)(35.1±13.2) cm3,125I seed brachytherapy alone;(c)(6±2.3) cm3,the combination therapy(P0.05,compared with PMCT alone or 125I seed brachytherapy alone);(d)(198.1±72.1) cm3,no treatment(P0.01,compared with treatment group a,b and c).Conclusion The combination therapy with PMCT and 125I seed brachytherapy for liver cancer in the rabbit VX2 tumor model is a new combination therapy with good effect by making up the deficiency of PMCT alone or 125I seed brachytherapy alone.
What problem does this paper attempt to address?